Nimesh Patel, MD

Anti-VEGF therapy remains the standard of care for center-involved DME, yet eye care competes with dialysis, amputations, and other demands. Dr. Patel explains how disease severity should guide scheduling priority.

Diabetes drives the nation's costliest chronic disease burden, and retinopathy affects most patients over time. The panel outlines the scale of DME and why its economic consequences extend well beyond the eye clinic.